EU Medical Devices Regulation (MDR 2017/745) MDR-Art.122_123: Entry into force and date of application (Articles 122-123)

Article 122 repealed Council Directives 90/385/EEC (AIMDD) and 93/42/EEC (MDD) with effect from 26 May 2021 (later partly extended via Article 120 as amended by (EU) 2023/607). Article 123 provides that the Regulation entered into force on 25 May 2017 and applied from 26 May 2021 (subject to the Article 120 transitional provisions for legacy devices).

Maintained by Gerard BlokdykVerified against the published standard 31 May 2026Control text last updated 21 May 2026

Other controls in MDR - PMS + Vigilance + Market Surveillance + Final (Ch VII-X)

MDR-Art.103_104_105_106_107_108 Medical Device Coordination Group + EU expert panels + EU reference laboratories (Articles 103-108)
MDR-Art.109_110_111_112_113_115 Confidentiality, data protection, funding, civil liability and penalties (Articles 109-115)
MDR-Art.120 Transitional provisions (Article 120 as amended by (EU) 2023/607)
MDR-Art.83 Post-market surveillance system of the manufacturer (Article 83)
MDR-Art.84_85_86 PMS plan + PMS report + Periodic Safety Update Report (Articles 84-86)
MDR-Art.87_88_89_90_91_92 Vigilance + serious incident reporting + FSCAs + trend reporting (Articles 87-92)
MDR-Art.93_94_95_96_97_98 Market surveillance + Member-State competent authorities (Articles 93-98)

Query this from an agent

The graph holds this control, the 0 it maps to, and the evidence behind each claim, over MCP and REST.

MCP endpoint All EU Medical Devices Regulation (MDR 2017/745) controls